Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 10;4(4):CD015112.
doi: 10.1002/14651858.CD015112.pub3.

Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings

Alexandru Marian Constantin  1   2 , Kukuh Noertjojo  3 , Isolde Sommer  4 , Ana Beatriz Pizarro  5 , Emma Persad  4   6 , Solange Durao  7 , Barbara Nussbaumer-Streit  4 , Damien M McElvenny  8   9 , Sarah Rhodes  10 , Craig Martin  3 , Olivia Sampson  3 , Karsten Juhl Jørgensen  11 , Matteo Bruschettini  12   13
Affiliations

Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings

Alexandru Marian Constantin et al. Cochrane Database Syst Rev. .

Abstract

Background: Although many people infected with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) experience no or mild symptoms, some individuals can develop severe illness and may die, particularly older people and those with underlying medical problems. Providing evidence-based interventions to prevent SARS-CoV-2 infection has become more urgent with the potential psychological toll imposed by the coronavirus disease 2019 (COVID-19) pandemic. Controlling exposures to occupational hazards is the fundamental method of protecting workers. When it comes to the transmission of viruses, workplaces should first consider control measures that can potentially have the most significant impact. According to the hierarchy of controls, one should first consider elimination (and substitution), then engineering controls, administrative controls, and lastly, personal protective equipment. This is the first update of a Cochrane review published 6 May 2022, with one new study added.

Objectives: To assess the benefits and harms of interventions in non-healthcare-related workplaces aimed at reducing the risk of SARS-CoV-2 infection compared to other interventions or no intervention.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, Web of Science Core Collections, Cochrane COVID-19 Study Register, World Health Organization (WHO) COVID-19 Global literature on coronavirus disease, ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform, and medRxiv to 13 April 2023.

Selection criteria: We included randomised controlled trials (RCTs) and non-randomised studies of interventions. We included adult workers, both those who come into close contact with clients or customers (e.g. public-facing employees, such as cashiers or taxi drivers), and those who do not, but who could be infected by coworkers. We excluded studies involving healthcare workers. We included any intervention to prevent or reduce workers' exposure to SARS-CoV-2 in the workplace, defining categories of intervention according to the hierarchy of hazard controls (i.e. elimination; engineering controls; administrative controls; personal protective equipment).

Data collection and analysis: We used standard Cochrane methods. Our primary outcomes were incidence rate of SARS-CoV-2 infection (or other respiratory viruses), SARS-CoV-2-related mortality, adverse events, and absenteeism from work. Our secondary outcomes were all-cause mortality, quality of life, hospitalisation, and uptake, acceptability, or adherence to strategies. We used the Cochrane RoB 2 tool to assess risk of bias, and GRADE methods to evaluate the certainty of evidence for each outcome.

Main results: We identified 2 studies including a total of 16,014 participants. Elimination-of-exposure interventions We included one study examining an intervention that focused on elimination of hazards, which was an open-label, cluster-randomised, non-inferiority trial, conducted in England in 2021. The study compared standard 10-day self-isolation after contact with an infected person to a new strategy of daily rapid antigen testing and staying at work if the test is negative (test-based attendance). The trialists hypothesised that this would lead to a similar rate of infections, but lower COVID-related absence. Staff (N = 11,798) working at 76 schools were assigned to standard isolation, and staff (N = 12,229) working at 86 schools were assigned to the test-based attendance strategy. The results between test-based attendance and standard 10-day self-isolation were inconclusive for the rate of symptomatic polymerase chain reaction (PCR)-positive SARS-CoV-2 infection (rate ratio (RR) 1.28, 95% confidence interval (CI) 0.74 to 2.21; 1 study; very low-certainty evidence). The results between test-based attendance and standard 10-day self-isolation were inconclusive for the rate of any PCR-positive SARS-CoV-2 infection (RR 1.35, 95% CI 0.82 to 2.21; 1 study; very low-certainty evidence). COVID-related absenteeism rates were 3704 absence days in 566,502 days-at-risk (6.5 per 1000 working days) in the control group and 2932 per 539,805 days-at-risk (5.4 per 1000 working days) in the intervention group (RR 0.83, 95% CI 0.55 to 1.25). We downgraded the certainty of the evidence to low due to imprecision. Uptake of the intervention was 71% in the intervention group, but not reported for the control intervention. The trial did not measure our other outcomes of SARS-CoV-2-related mortality, adverse events, all-cause mortality, quality of life, or hospitalisation. We found seven ongoing studies using elimination-of-hazard strategies, six RCTs and one non-randomised trial. Administrative control interventions We found one ongoing RCT that aims to evaluate the efficacy of the Bacillus Calmette-Guérin (BCG) vaccine in preventing COVID-19 infection and reducing disease severity. Combinations of eligible interventions We included one non-randomised study examining a combination of elimination of hazards, administrative controls, and personal protective equipment. The study was conducted in two large retail companies in Italy in 2020. The study compared a safety operating protocol, measurement of body temperature and oxygen saturation upon entry, and a SARS-CoV-2 test strategy with a minimum activity protocol. Both groups received protective equipment. All employees working at the companies during the study period were included: 1987 in the intervention company and 1798 in the control company. The study did not report an outcome of interest for this systematic review. Other intervention categories We did not find any studies in this category.

Authors' conclusions: We are uncertain whether a test-based attendance policy affects rates of PCR-positive SARS-CoV-2 infection (any infection; symptomatic infection) compared to standard 10-day self-isolation amongst school and college staff. A test-based attendance policy may result in little to no difference in absenteeism rates compared to standard 10-day self-isolation. The non-randomised study included in our updated search did not report any outcome of interest for this Cochrane review. As a large part of the population is exposed in the case of a pandemic, an apparently small relative effect that would not be worthwhile from the individual perspective may still affect many people, and thus become an important absolute effect from the enterprise or societal perspective. The included RCT did not report on any of our other primary outcomes (i.e. SARS-CoV-2-related mortality and adverse events). We identified no completed studies on any other interventions specified in this review; however, eight eligible studies are ongoing. More controlled studies are needed on testing and isolation strategies, and working from home, as these have important implications for work organisations.

Trial registration: ClinicalTrials.gov NCT04630054 NCT04878809 https://clinicaltrials.gov/ct2/show/NCT04739462 https://clinicaltrials.gov/ct2/show/NCT05197725 https://clinicaltrials.gov/ct2/show/NCT05777720 NCT05248399 NCT04726371 NCT04439045 NCT04977050 NCT05197673 NCT05539482 NCT04859699.

PubMed Disclaimer

Conflict of interest statement

AMC has no interest to declare.

KN is a full‐time employee of WorkSafeBC.

IS has no interest to declare.

ABP has no interest to declare.

EP has no interest to declare.

SD has no interest to declare.

BNS has no interest to declare.

DM has no interest to declare.

SR: part of her salary was paid to her institution through funding from the National Core Study 'PROTECT' programme, managed by the Health and Safety Executive on behalf of HM Government (UK). The grant was from 1 October 2020 to 31 March 2022. She is the statistical editor for Cochrane Gut.

CM is a full‐time employee of WorkSafeBC.

OS is a full‐time employee of WorkSafeBC.

KJJ has no interest to declare.

MB has no interest to declare.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary.
1.1
1.1. Analysis
Comparison 1: Test‐based attendance versus standard 10‐day self‐isolation, Outcome 1: Rates of symptomatic PCR‐positive SARS‐CoV‐2 infection
1.2
1.2. Analysis
Comparison 1: Test‐based attendance versus standard 10‐day self‐isolation, Outcome 2: Rates of any positive PCR SARS‐CoV‐2 infection
1.3
1.3. Analysis
Comparison 1: Test‐based attendance versus standard 10‐day self‐isolation, Outcome 3: Absenteeism
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Vitale 2022 {published data only}
    1. Vitale E, Vella F, Indelicato G, Canalella A, Briguglio S, Pittari V, et al. SARS-CoV-2 transmission prevention model application in a large retail company before the vaccine introduction. Frontiers in Public Health 2022;10:908690. [DOI: 10.3389/fpubh.2022.908690] [PMID: ] - DOI - PMC - PubMed
Young 2021 {published data only}
    1. Young BC, Eyre DW, Kendrick S, White C, Smith S, Beveridge G, et al. Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial. Lancet 2021;398(10307):1217-29. [DOI: 10.1016/S0140-6736(21)01908-5] [PMID: ] - DOI - PMC - PubMed

References to studies excluded from this review

Abaluck 2022 {published data only}
    1. Abaluck J, Kwong LH, Styczynski A, Haque A, Kabir MA, Bates-Jefferys E, et al. Impact of community masking on COVID-19: a cluster-randomized trial in Bangladesh. Science 2022;375(6577):eabi9069. [DOI: 10.1126/science.abi9069] - DOI - PMC - PubMed
Abdel‐Qader 2022 {published data only}
    1. Abdel-Qader DH, Al Meslamani AZ, Al Mazrouei N, El-Shara AA, El Sharu H, Merghani Ali E, et al. Virtual coaching delivered by pharmacists to prevent COVID-19 transmission. Sage Journals, Hospital Pharmacy 2022;57(2):300-8. [DOI: 10.1177/00185787211032354] - DOI - PMC - PubMed
ACTRN12621000567820 {published data only}
    1. ACTRN12621000567820. Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a parallel crossover randomised controlled trial. https://anzctr.org.au/ACTRN12621000567820.aspx (first posted 4 May 2021). - PMC - PubMed
Amrein 2022 {published data only}
    1. Amrein MA, Ruschetti GG, Baeder C, Bamert M, Inauen J. Mobile intervention to promote correct hand hygiene at key times to prevent COVID-19 in the Swiss adult general population: study protocol of a multiphase optimisation strategy. BMJ Open 2022;12(3):e055971. [DOI: 10.1136/bmjopen-2021-055971] - DOI - PMC - PubMed
Asaoka 2022 {published data only}
    1. Asaoka H, Sasaki N, Imamura K, Kuroda R, Tsuno K, Kawakami N. Effects of workplace measures against COVID-19 on psychological distress of full-time employees: A 12-month prospective study in the COVID-19 pandemic. Scandinavian Journal of Work, Environment & Health 2022;48(6):468-78. [DOI: 10.5271/sjweh.4030] - DOI - PMC - PubMed
Bahety 2021 {published data only}
    1. Bahety G, Bauhoff S, Patel D, Potter J. Texts don't nudge: An adaptive trial to prevent the spread of COVID-19 in India. Journal of Development Economics November 2021;153:102747. [DOI: 10.1016/j.jdeveco.2021.102747] - DOI - PMC - PubMed
Bhaskar 2020 {published data only}
    1. Bhaskar ME, Arun S. SARS-CoV-2 infection among community health workers in India before and after use of face shields. JAMA 2020;324(13):1348-9. [DOI: 10.1001/jama.2020.15586] [PMID: ] - DOI - PMC - PubMed
Bielecki 2021 {published data only}
    1. Bielecki M, Züst R, Siegrist D, Meyerhofer D, Crameri GAG, Stanga Z, et al. Social distancing alters the clinical course of COVID-19 in young adults: a comparative cohort study. Clinical Infectious Diseases 2021;72(4):598-603. [DOI: 10.1093/cid/ciaa889] [PMID: ] - DOI - PMC - PubMed
Bundgaard 2021 {published data only}
    1. Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, Mariager AF, Schytte N, Buchwald C, et al. Face masks for the prevention of COVID-19 - rationale and design of the randomised controlled trial DANMASK-19. Danish Medical Journal 2020;67(9):1-10. [CLINICALTRIALS.GOV: NCT04337541] [PMID: ] - PubMed
    1. Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, Buchwald C, Todsen T, Norsk JB. Effectiveness of adding a mask recommendation to other public health measures to prevent SARS-CoV-2 infection in Danish mask wearers: a randomized controlled trial. Annals of Internal Medicine 2021;174(3):335-43. [DOI: 10.7326/M20-6817] [PMID: ] - DOI - PMC - PubMed
Cave 2021 {published data only}
    1. Cave KM, Kelley AM, Feltman KA, Gerstner JA, Stewart JL, Crowley JS. Aircrew performance and safety while using protective masks in response to coronavirus disease. Aerospace Medicine and Human Performance 2021;92(4):274-80. [DOI: 10.3357/AMHP.5751.2021] [PMID: ] - DOI - PubMed
Colom‐Cadena 2023 {published and unpublished data}
    1. Colom-Cadena A, Martínez-Riveros H, Bordas A, Alonso-García L, Montoro-Fernández M, Romano-deGea P, et al. Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees. Frontiers in Pediatrics 2023;10:975454. [DOI: 10.3389/fped.2022.975454] [PMID: ] - DOI - PMC - PubMed
Edwards 2021 {published data only}
    1. Edwards NJ, Widrick R, Wilmes J, Breisch B, Gerschefske M, Sullivan J, et al. Reducing COVID-19 airborne transmission risks on public transportation buses: an empirical study on aerosol dispersion and control. Aerosol Science and Technology 2021;55(12):1378-97. [DOI: 10.1080/02786826.2021.1966376] - DOI
Falsey 1999 {published data only}
    1. Falsey AR, Criddle MM, Kolassa JE, McCann RM, Brower CA, Hall WJ. Evaluation of a handwashing intervention to reduce respiratory illness rates in senior day-care centers. Infection Control & Hospital Epidemiology 1999;20(3):200-2. [DOI: 10.1086/501612] [PMID: ] - DOI - PubMed
Faucher 2021 {published data only}
    1. Faucher B, Assab R, Roux J, Levy-Bruhl D, Kiem CT, Cauchemez S, et al. Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19. Nature Communications 2022;13:1414. [DOI: ] - PMC - PubMed
    1. Faucher B, Assab R, Roux J, Levy-Bruhl D, Kiem CT, Cauchemez S, et al. Reactive vaccination of workplaces and schools against COVID-19. medRxiv 2021. [DOI: ] - PMC - PubMed
Gupta 2021 {published data only}
    1. Gupta A, Kunte R, Goyal N, Ray S, Singh K. A comparative analysis of control measures on-board ship against COVID-19 and similar novel viral respiratory disease outbreak: Quarantine ship or disembark suspects? Medical Journal Armed Forces India 2021;77:S430-6. [DOI: 10.1016/j.mjafi.2020.06.003] - DOI - PMC - PubMed
Guy 2021 {published data only}
    1. Guy GP Jr, Lee FC, Sunshine G, McCord R, Howard-Williams M, Kompaniyets L, et al. Association of state-issued mask mandates and allowing on-premises restaurant dining with county-level COVID-19 case and death growth rates - United States, March 1-December 31, 2020. Morbidity and Mortality Weekly Report 2021;70(10):350. [DOI: 10.15585/mmwr.mm7010e3external icon] - PMC - PubMed
Herstein 2021 {published data only}
    1. Herstein JJ, Degarege A, Stover D, Austin C, Schwedhelm MM, Lawler JV, et al. Characteristics of SARS-CoV-2 transmission among meat processing workers in Nebraska, USA, and effectiveness of risk mitigation measures. Emerging Infectious Diseases Journal 2021;27(4):1032-9. [DOI: 10.3201/eid2704.204800] - DOI - PMC - PubMed
Iddins 2021 {published data only}
    1. Iddins BO, Waugh MH, Buck B, Cato T, Graham DE, Attia K, et al. Benchmarking SARS CoV-2 infection in the workplace to support continuity of operations. Journal of Occupational and Environmental Medicine 2021;63(7):548-56. [DOI: 10.1097/JOM.0000000000002188] [PMID: ] - DOI - PMC - PubMed
Liow 2022 {published data only}
    1. Liow MHL, Lee LC, Tan NCK, Tan HK, Chow W, Wee GLE, et al. Personal protective equipment training for non-healthcare workers in the Covid-19 pandemic: Effectiveness of an evidence-based skills training framework. Infection, Disease and Health 2022;27(1):38-48. [DOI: 10.1016/j.idh.2021.09.040] - DOI - PMC - PubMed
Ma 2020 {published data only}
    1. Ma QX, Shan H, Zhang HL, Li GM, Yang RM, Chen JM. Potential utilities of mask-wearing and instant hand hygiene for fighting SARS-CoV-2. Journal of Medical Virology 2020;92(9):1567-71. [DOI: 10.1002/jmv.25805] [PMID: ] - DOI - PMC - PubMed
Marshall 2020 {published data only}
    1. Marshall DL, Bois F, Jensen SKS, Linde SA, Higby R, Rémy-McCort Y, et al. Sentinel coronavirus environmental monitoring can contribute to detecting asymptomatic SARS-CoV-2 virus spreaders and can verify effectiveness of workplace COVID-19 controls. Microbial Risk Analysis 2020;16:100137. [DOI: 10.1016/j.mran.2020.100137] [PMID: ] - DOI - PMC - PubMed
NCT04619407 {published data only}
    1. NCT04619407. Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers (COKITS). https://ichgcp.net/clinical-trials-registry/NCT04619407 (first posted 4 November 2020).
NCT04739462 {unpublished data only}
    1. NCT04739462. SMS Maama Project COVID-19. https://clinicaltrials.gov/ct2/show/NCT04739462 (first posted 4 February 2021).
NCT04740320 {published data only}
    1. NCT04740320. COVID-19 SARS-CoV-2 screening protocol. clinicaltrials.gov/ct2/show/NCT04740320 (first posted 5 February 2021).
NCT04847479 {published data only}
    1. NCT04847479. COVID-19 Close Contact Self-Testing Study (CloseST). https://clinicaltrials.gov/ct2/show/NCT04847479 (first posted 19 April 2021).
NCT05008627 {published data only}
    1. NCT05008627. Personal protection equipment and SARS-CoV-2 contamination. clinicaltrials.gov/ct2/show/NCT05008627 (first posted 17 August 2021).
NCT05022472 {published data only}
    1. NCT05022472. Project 2VIDA! COVID-19 vaccine intervention delivery for adults in southern California. clinicaltrials.gov/ct2/show/NCT05022472 (first posted 26 August 2021).
NCT05197725 {published data only}
    1. NCT05197725. Face masks to reduce SARS-CoV-2 infections (COVID-19) in Bangladesh. https://clinicaltrials.gov/ct2/show/NCT05197725 (first posted 19 January 2022).
NCT05436795 {published data only}
    1. NCT05436795. A randomized controlled trial of a digital, self-testing strategy for COVID-19 infection in South Africa. https://clinicaltrials.gov/show/NCT05436795 (first posted 29 June 2022).
NCT05777720 {published data only}
    1. NCT05777720. Cluster-randomized trial of air filtration and ventilation to reduce Covid19 spread in homes. https://clinicaltrials.gov/ct2/show/NCT05777720 (first posted 21 March 2023).
Nemoto 2021 {published data only}
    1. Nemoto N, Dhillon S, Fink S, Holman EJ, Cope AK, Dinh TH, et al. Evaluation of Test to Stay Strategy on Secondary and Tertiary Transmission of SARS-CoV-2 in K-12 Schools - Lake County, Illinois, August 9-October 29, 2021. Morbidity and Mortality Weekly Report 2021;70(5152):1778-81. [DOI: 10.15585/mmwr.mm705152e2] - DOI - PMC - PubMed
Smith 2022 {published data only}
    1. Smith SR, Hagger MS, Keech JJ, Moyers SA, Hamilton K. Improving hand hygiene behavior using a novel theory-based intervention during the COVID-19 pandemic. Annals of Behavioral Medicine 2022;56(11):1157-73. [DOI: 10.1093/abm/kaac041] - DOI - PMC - PubMed
Tagliabue 2021 {published data only}
    1. Tagliabue M, Ridolfo AL, Pina P, Rizzolo G, Belbusti S, Antinori S, et al. Preventing COVID-19 in assisted living facilities: an impossible task pending vaccination roll out. Preventive Medicine Reports 2021;23:101471. [DOI: 10.1016/j.pmedr.2021.101471] [PMID: ] - DOI - PMC - PubMed
Vandormael 2020 {published data only}
    1. Vandormael A, Adam M, Greuel M, Bärnighausen T. A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial. Trials 2020;21(1):469. [DOI: 10.1186/s13063-020-04449-1] - DOI - PMC - PubMed
Varela 2022 {published data only}
    1. Varela AR, Gurruchaga AP, Restrepo SR, Martin JD, Landazabal YDC, Tamayo-Cabeza G, et al. Effectiveness and adherence to closed face shields in the prevention of COVID-19 transmission: a non-inferiority randomized controlled trial in a middle-income setting (COVPROSHIELD). Trials 2022;23(1):698. [DOI: 10.1186/s13063-022-06606-0] - DOI - PMC - PubMed
Zhang 2022 {published data only}
    1. Zhang X, Owen G, Green MA, Buchan I, Barr B. Evaluating the impacts of tiered restrictions introduced in England, during October and December 2020 on COVID-19 cases: a synthetic control study. BMJ Open 2022;12(4):e054101. [DOI: 10.1136/bmjopen-2021-054101] - DOI - PMC - PubMed

References to studies awaiting assessment

NCT05248399 {published data only}
    1. NCT05248399. Vale+ Tu Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19. https://clinicaltrials.gov/study/NCT05248399.

References to ongoing studies

ISRCTN46750688 {published data only}ISRCTN46750688
    1. Noakes C, Brown C, Beggs C, Avital E, Darling J, Fletcher L, et al. Phase 1 trial of covid-19 airborne transmission prevention technologies: Classroom Air Cleaning Technology (Class-ACT) Study. https://www.isrctn.com/ISRCTN46750688.
ISRCTN63437172 {published data only}ISRCTN63437172
    1. Air Filtration to prevent symptomatic winter Respiratory Infections (including COVID-19) in care homes: the AFRI-c cluster randomised controlled trial with a nested internal pilot, process and economic evaluations (AFRI-c). https://www.isrctn.com/ISRCTN63437172. - PMC - PubMed
Levison 2023 {unpublished data only}
    1. Levison JH, Krane D, Donelan K, Aschbrenner K, Trieu HD, Chau C, et al. Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial. Contemporary Clinical Trials 2023;125:107053. [DOI: 10.1016/j.cct.2022.107053] [PMID: ] - DOI - PMC - PubMed
NCT04439045 {published data only}
    1. NCT04439045. Efficacy and safety of VPM1002 in reducing SARS-CoV-2 (COVID-19) infection rate and severity (COBRA). https://clinicaltrials.gov/ct2/show/NCT04439045 (first received 19 June 2020).
NCT04977050 {published data only}
    1. NCT04977050. The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners. https://clinicaltrials.gov/study/NCT04977050.
NCT05197673 {published data only}
    1. NCT05197673. Identifying risks of COVID-19 outbreaks in work settings and the implications for control measures. clinicaltrials.gov/ct2/show/NCT05197673 (first received 19 January 2022).
NCT05539482 {published data only}
    1. NCT05539482. Community-Based Health Education Programs for the Early Detection of, and Vaccination Against, COVID-19 and the Adoption of Self-Protective Measures of Hong Kong Residents. https://clinicaltrials.gov/study/NCT05539482.
Ramirez 2024 {unpublished data only}
    1. Ramirez M, Shah PD, Chu HY, Garza L, Linde S, Garrison MM, et al. Reopening schools safely and educating youth (ROSSEY) study: Protocol for a community-based, cluster randomized controlled trial. Contemporary Clinical Trials 2024;107480. [DOI: 10.1016/j.cct.2024.107480] [PMID: ] - DOI - PMC - PubMed

Additional references

Allen 2021
    1. Allen TD, Merlo K, Lawrence RC, Slutsky J, Gray CE. Boundary management and work-nonwork balance while working from home. Applied Psychology 2021;70(1):60-84.
Althouse 2020
    1. Althouse BM, Wenger EA, Miller JC, Scarpino SV, Allard A, Hébert-Dufresne L, et al. Superspreading events in the transmission dynamics of SARS-CoV-2: opportunities for interventions and control. PLOS Biology 2020;18(11):e3000897. - PMC - PubMed
Altmann 2021
    1. Altmann DM, Boyton RJ, Beale R. Immunity to SARS-CoV-2 variants of concern. Science 2021;371(6534):1103-4. - PubMed
Baptista 2021
    1. Baptista MC, Burton WN, Pawlecki B, Pransky G. A physician's guide for workers' return to work during COVID-19 pandemic. Journal of Occupational and Environmental Medicine/American College of Occupational and Environmental Medicine 2021;63(3):199-220. - PMC - PubMed
Berlin 2020
    1. Berlin DA, Gulick RM, Martinez FJ. Severe COVID-19. New England Journal of Medicine 2020;383(25):2451-60. - PubMed
Bruchfeld 2020
    1. Bruchfeld J, Åhsberg E, Österberg M, Edebert I, Hellberg C, Lintamo L, et al. Long-term symptoms of the disease COVID-19; December 2020. www.sbu.se/contentassets/a57f9380e8404670b27e655c72ebaad3/long_term-symp....
Burdorf 2023
    1. Burdorf A, Rugulies R. The importance of occupation in the development of the COVID-19 pandemic. Scandinavian Journal of Work, Environment & Health 2023;49(4):231-3. [DOI: 10.5271/sjweh.4094] - DOI - PMC - PubMed
Burns 2021
    1. Burns J, Movsisyan A, Stratil JM, Biallas RL, Coenen M, Emmert-Fees KM, et al. International travel-related control measures to contain the COVID-19 pandemic: a rapid review. Cochrane Database of Systematic Reviews 2021, Issue 3. Art. No: CD013717. [DOI: 10.1002/14651858.CD013717.pub2] - DOI - PMC - PubMed
Burton 2020a
    1. Burton MJ, Clarkson JE, Goulao B, Glenny A-M, McBain AJ, Schilder AG, et al. Antimicrobial mouthwashes (gargling) and nasal sprays to protect healthcare workers when undertaking aerosol-generating procedures (AGPs) on patients without suspected or confirmed COVID-19 infection. Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No: CD013628. [DOI: 10.1002/14651858.CD013628.pub2] - DOI - PMC - PubMed
Burton 2020b
    1. Burton MJ, Clarkson JE, Goulao B, Glenny A-M, McBain AJ, Schilder AG, et al. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them. Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No: CD013627. [DOI: 10.1002/14651858.CD013627.pub2] - DOI - PMC - PubMed
Burton 2020c
    1. Burton MJ, Clarkson JE, Goulao B, Glenny A-M, McBain AJ, Schilder AG, et al. Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection. Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No: CD013626. [DOI: 10.1002/14651858.CD013626.pub2] - DOI - PMC - PubMed
Byambasuren 2020
    1. Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada December 2020;5(4):223-234. [DOI: 10.3138/jammi-2020-0030] - DOI - PMC - PubMed
Campbell 2001
    1. Campbell MK, Mollison J, Grimshaw JM. Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Statistics in Medicine 2001;20(3):391-9. - PubMed
Campbell 2020
    1. Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 2020;368:l6890. [DOI: 10.1136/bmj.l6890] - DOI - PMC - PubMed
CCOHS 2020
    1. Canadian Centre for Occupational Health and Safety (CCOHS). COVID-19: Workplace Health and Safety Guide; August 2020. www.ccohs.ca/products/publications/pdf/pandemiccovid19/covid-health-safe....
CDC 2021a
    1. Centers for Disease Control and Prevention (CDC). COVID-19 - community, work, and school. www.cdc.gov/coronavirus/2019-ncov/community/index.html (accessed 5 May 2021).
CDC 2021b
    1. Centers for Disease Control and Prevention (CDC). SARS-CoV-2 transmission. www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/sars-cov-2-tran... (accessed 10 May 2021).
Chotirmall 2021
    1. Chotirmall SH, Leither LM, Çoruh B, Chan LL, Joudi AM, Brown SM, et al. Update in COVID-19. American Journal of Respiratory and Critical Care Medicine 2021;1:1-46. [DOI: 10.1164/rccm.202102-0415UP] - DOI - PMC - PubMed
Chou 2020
    1. Chou R, Dana T, Buckley DI, Selph S, Fu R, Totten AM. Epidemiology of and risk factors for coronavirus infection in health care workers: a living rapid review. Annals of Internal Medicine 2020;173(2):120-36. - PMC - PubMed
CISA 2021
    1. The Cybersecurity and Infrastructure Security Agency (CISA). Advisory memorandum on ensuring essential critical infrastructure workers' ability to work during the COVID-19 response, 10 May 2021. www.cisa.gov/publication/guidance-essential-critical-infrastructure-work... (accessed 27 April 2022).
Clancy 2021
    1. Clancy C, Delungahawatta T, Dunne CP. Hand hygiene-related clinical trials reported between 2014 and 2020: a comprehensive systematic review. Journal of Hospital Infection 2021;111:6-26. [DOI: 10.1016/j.jhin.2021.03.007] [PMID: ] - DOI - PMC - PubMed
COMET 2021
    1. COMET. Core outcome set developers’ response to COVID-19 (April 2021). www.comet-initiative.org/Studies/Details/1538 (accessed prior to 28 August 2021).
Covidence [Computer program]
    1. Covidence. Version accessed 22 February 2024. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.
Davis 2023
    1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology 2023;21(3):133-46. [DOI: 10.1038/s41579-022-00846-2] - DOI - PMC - PubMed
Deeks 2022
    1. Deeks JJ, Higgins JPT, Altman DG, editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.
Delamater 2019
    1. Delamater PL, Street EJ, Leslie TF, Yang YT, Jacobsen KH. Complexity of the basic reproduction number (R0). Emerging Infectious Diseases 2019;25(1):1-4. - PMC - PubMed
Donaldson 2020
    1. Donaldson AI. Aerosols in meat plants as possible cause of COVID-19 spread. Veterinary Record 2020;187(1):34-5. [DOI: 10.1136/vr.m2702] - DOI - PMC - PubMed
Durand‐Moreau 2020
    1. Durand-Moreau Q, Adises A, Mackenzie G, Bowley J, Straube S, Hui X, et al. COVID-19 in meat and poultry facilities: a rapid review and lay media analysis; June 2020. www.cebm.net/covid-19/what-explains-the-high-rate-of-sars-cov-2-transmis... (accessed prior to 28 August 2021).
Elbourne 2002
    1. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analysis involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9. - PubMed
Faghri 2021
    1. Faghri PD, Dobson M, Landsbergis P, Schnall PL. COVID-19 pandemic: what has work got to do with it? Journal of Occupational and Environmental Medicine/American College of Occupational and Environmental Medicine 2021;63(4):e245-9. - PubMed
Fomenko 2021
    1. Fomenko O, Ruser J. The early impact of COVID-19 on workers’ compensation claim composition. www.wcrinet.org/reports/the-early-impact-of-covid-19-on-workers-compensa... (accessed 27 April 2022).
Gandhi 2020
    1. Gandhi RT, Lynch JB, Del Rio C. Mild or moderate COVID-19. New England Journal of Medicine 2020;383(18):1757-66. [DOI: 10.1056/NEJMcp2009249] [PMID: ] - DOI - PubMed
GRADEpro GDT [Computer program]
    1. GRADEpro GDT. Version accessed 1 September 2021. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.
Günther 2020
    1. Günther T, Czech-Sioli M, Indenbirken D, Robitaille A, Tenhaken P, Exner M, et al. SARS-CoV-2 outbreak investigation in a German meat processing plant. EMBO Molecular Medicine 2020;12(12):e13296. [DOI: 10.15252/emmm.202013296] - DOI - PMC - PubMed
Haug 2020
    1. Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V, et al. Ranking the effectiveness of worldwide COVID-19 government interventions. Nature Human Behaviour 2020;4(12):1303-12. - PubMed
Herstein 2021
    1. Herstein JJ, Degarege A, Stover D, Austin C, Schwedhelm MM, Lawler JV, et al. Characteristics of SARS-CoV-2 transmission among meat processing workers in Nebraska, USA, and effectiveness of risk mitigation measures. Emerging Infectious Diseases 2021;4(4):1032-8. [DOI: 10.3201/eid2704.204800] - DOI - PMC - PubMed
Higgins 2023
    1. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.
Houghton 2020
    1. Houghton C, Meskell P, Delaney H, Smalle M, Glenton C, Booth A, et al. Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis. Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No: CD013582. [DOI: 10.1002/14651858.CD013582] - DOI - PMC - PubMed
Htay 2020
    1. Htay MN, Marzo RR, AlRifai A, Kamberi F, El-Abasiri RA, Nyamache JM, et al. Immediate impact of COVID-19 on mental health and its associated factors among healthcare workers: a global perspective across 31 countries. Journal of Global Health 2020;10(2):020381. - PMC - PubMed
Ingram 2021
    1. Ingram C, Downey V, Roe M, Chen Y, Archibald M, Kallas KA, et al. COVID-19 prevention and control measures in workplace settings: a rapid review and meta-analysis. International Journal of Environmental Research and Public Health 2021;18(15):7847. [DOI: 10.3390/ijerph18157847] [PMID: ] - DOI - PMC - PubMed
Jefferson 2023
    1. Jefferson T, Dooley L, Ferroni E, Al-Ansary LA, Driel ML, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Systematic Reviews 2023, Issue 1. Art. No: CD006207. [DOI: 10.1002/14651858.CD006207.pub6] - DOI - PMC - PubMed
Khan 2020
    1. Khan RF, Meyer JD. How does the hiearchy of controls integrate with the epidemiologic triangle to help address and understand transmission of SARS-CoV-2? Journal of Occupational and Environmental Medicine 2020;62(11):e665-8. - PubMed
Kim 2020
    1. Kim R, Nachman S, Fernandes R, Meyers K, Taylor M, LeBlanc D, et al. Comparison of COVID-19 infections among healthcare workers and non-healthcare workers. PLOS ONE 2020;15(12):e0241956. [DOI: 10.1371/journal.pone.0241956] - DOI - PMC - PubMed
Krishnaratne 2020
    1. Krishnaratne S, Pfadenhauer LM, Coenen M, Geffert K, Jung-Sievers C, Klinger C, et al. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review. Cochrane Database of Systematic Reviews 2020, Issue 12. Art. No: CD013812. [DOI: 10.1002/14651858.CD013812] [PMID: ] - DOI - PMC - PubMed
Kumar 2021
    1. Kumar S, Singh R, Kumari N, Karmakar S, Behera M, Siddiqui AJ, et al. Current understanding of the influence of environmental factors on SARS-CoV-2 transmission, persistence, and infectivity. Environmental Science and Pollution Research 2021;28(6):6267-88. [DOI: 10.1007/s11356-020-12165-1] - DOI - PMC - PubMed
Lauer 2020
    1. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of Internal Medicine 2020;172:577-82. - PMC - PubMed
Mendez‐Brito 2021
    1. Mendez-Brito A, El Bcheraoui C, Pozo-Martin F. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19. Journal of Infection 2021;83(3):281-93. [DOI: 10.1016/j.jinf.2021.06.018] [PMID: ] - DOI - PMC - PubMed
Meyerowitz‐Katz 2020
    1. Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. International Journal of Infectious Diseases 2020;101:138-48. - PMC - PubMed
Middleton 2020
    1. Middleton J, Reintjes R, Lopes H. Meat plants - a new front line in the COVID-19 pandemic. BMJ 2020;370:m2716. [DOI: 10.1136/bmj.m2716] - DOI - PubMed
Moore 2021
    1. Moore JP. Approaches for optimal use of different COVID-19 vaccines: issues of viral variants and vaccine efficacy. JAMA 2021;325(13):1251-2. - PubMed
Morris 2020
    1. Morris DH, Yinda KC, Gamble A, Rossine FW, Huang Q, Bushmaker T, et al. Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses. eLife 2021 Jul 13;10:e65902. [DOI: 10.7554/eLife.65902] - DOI - PMC - PubMed
Nagraj 2020
    1. Nagraj SK, Eachempati P, Paisi M, Nasser M, Sivaramakrishnan G, Verbeek JH. Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases. Cochrane Database of Systematic Reviews 2020, Issue 10. Art. No: CD013686. [DOI: 10.1002/14651858.CD013686.pub2] - DOI - PMC - PubMed
Nguyen 2020
    1. Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo CG, Ma W, et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. The Lancet Public Health 2020;5(9):e475-83. - PMC - PubMed
NHS 2021
    1. National Health Service, UK (NHS). COVID-19 Vaccinations Archive. www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinatio... (accessed 20 November 2021).
Oran 2021
    1. Oran DP, Topol EJ. The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review. Annals of Internal Medicine 2021;174(5):655-62. [DOI: 10.7326/M20-6976] - DOI - PMC - PubMed
OSHA 2021
    1. Occupational Safety & Health Administration (OSHA). COVID-19 - control and prevention. www.osha.gov/coronavirus/control-prevention (accessed 5 May 2021).
Osmanov 2021
    1. Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk factors for long COVID in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. European Respiratory Journal 2021;1:1-21. [DOI: 10.1101/2021.04.26.21256110] - DOI - PMC - PubMed
O’Keeffe 2021
    1. O’Keeffe J, Eykelbosh A National Collaborating Centre for Environmental Health (NCCEH). Understanding SARS-CoV-2 transmission in the ongoing COVID-19 pandemic. Vancouver, BC: NCCEH. ncceh.ca/documents/evidence-review/understanding-transmission-sars-cov-2... (accessed 27 April 2022).
Page 2021
    1. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:71. [DOI: 10.1136/bmj.n71] - DOI - PMC - PubMed
Price 2020
    1. Price S. Surge response: how the panhandle handled one of the State's biggest COVID-19 outbreaks. Texas Medicine 2020;116(8):30-1. [PMID: ] - PubMed
Rauschenberg 2021
    1. Rauschenberg C, Schick A, Hirjak D, Seidler A, Paetzold I, Apfelbacher C, et al. Evidence synthesis of digital interventions to mitigate the negative impact of the COVID-19 pandemic on public mental health: rapid meta-review. Journal of Medical Internet Research 2021;23(3):e23365. [DOI: 10.2196/23365] [PMID: ] - DOI - PMC - PubMed
Reid 2021
    1. Reid M, Abdool-Karim Q, Geng E, Goosby E. How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities. PLOS Medicine 2021;18(3):e1003564. - PMC - PubMed
RevMan 2024 [Computer program]
    1. Review Manager (RevMan). Version 7.2.0. The Cochrane Collaboration, 2024. Available at revman.cochrane.org.
Roberts 2020
    1. Roberts JD, Dickinson KL, Koebele E, Neuberger L, Banacos N, Blanch-Hartigan D, et al. Clinicians, cooks, and cashiers: examining health equity and the COVID-19 risks to essential workers. Toxicology and Industrial Health 2020;36(9):689-702. [DOI: 10.1177/0748233720970439] - DOI - PMC - PubMed
Rosella 2022
    1. Rosella LC, Agrawal A, Gans J, Goldfarb A, Sennik S, Stein J. Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces. Science Advances 2022;8(8):eabm3608. [DOI: 10.1126/sciadv.abm3608] [PMID: ] - DOI - PMC - PubMed
Schünemann 2020
    1. Schünemann HJ, Vist GE, Higgins JPT, Santesso N, Deeks JJ, Glasziou P, et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.
Semple 2020
    1. Semple S, Cherrie JW. COVID-19: protecting worker health. Annals of Work Exposures and Health 2020;64(5):461-4. [DOI: 10.1093/annweh/wxaa033] - DOI - PMC - PubMed
Shaw 2020
    1. Shaw WS, Main CJ, Findley PA, Collie A, Kristman VL, Gross DP. Opening the workplace after COVID-19: what lessons can be learned from return-to-work research? Journal of Occupational Rehabilitation 2020;30(3):299-302. - PMC - PubMed
Sigahi 2021
    1. Sigahi TF, Kawasaki BC, Bolis I, Morioka SN. A systematic review on the impacts of COVID-19 on work: contributions and a path forward from the perspectives of ergonomics and psychodynamics of work. Human Factors and Ergonomics in Manufacturing & Service Industries 2021;10:10-100. [DOI: 10.1002/hfm.20889] - DOI - PMC - PubMed
Sim 2020
    1. Sim MR. The COVID-19 pandemic: major risks to healthcare and other workers on the front line. Occupational and Environmental Medicine 2020;77(5):281-2. [DOI: 10.1136/oemed-2020-106567] [PMID: ] - DOI - PubMed
Sterne 2016
    1. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919. [DOI: 10.1136/bmj.i4919] [PMID: ] - DOI - PMC - PubMed
Sterne 2019
    1. Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. - PubMed
Talic 2021
    1. Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, et al. Effectiveness of public health measures in reducing the incidence of COVID-19, SARS-CoV-2 transmission, and COVID-19 mortality: systematic review and meta-analysis. BMJ 2021;375:e068302. [DOI: 10.1136/bmj-2021-068302] [PMID: ] - DOI - PMC - PubMed
Taylor 2020
    1. Taylor CA, Boulos C, Almond D. Livestock plants and COVID-19 transmission. Proceedings of the National Academy of Sciences of the United States of America 2020;117(50):31706-15. [DOI: 10.1073/pnas.2010115117] - DOI - PMC - PubMed
UN 2008
    1. United Nations (UN). Detailed description of international standard industrial classification of all economic activities (ISIC). Statistical papers series 4. No. 4, Rev. 4. United Nations. 2008. unstats.un.org/unsd/publication/seriesm/seriesm_4rev4e.pdf.
Ursachi 2021
    1. Ursachi CȘ, Munteanu FD, Cioca G. The safety of slaughterhouse workers during the pandemic crisis. International Journal of Environmental Research and Public Health 2021;18(5):2633. [DOI: 10.3390/ijerph18052633] - DOI - PMC - PubMed
US OSHA 2020
    1. US Department of Labor Occupational Safety and Health Administration. Guidance on Preparing Workplaces for COVID-19. OSHA 3990-03 2020. www.osha.gov/sites/default/files/publications/OSHA3990.pdf.
Verbeek 2020
    1. Verbeek JH, Rajamaki B, Ijaz S, Sauni R, Toomey E, Blackwood B, et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No: CD011621. [DOI: 10.1002/14651858.CD011621.pub5] - DOI - PMC - PubMed
Viner 2020
    1. Viner RM, Russell SJ, Croker H, Packer J, Ward J, Stansfield C, et al. School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review. Lancet Child & Adolescent Health 2020;4(5):397-404. [DOI: 10.1016/S2352-4642(20)30095-X] [PMID: ] - DOI - PMC - PubMed
Waddell 2006
    1. Waddell G, Burton K. Is Work Good for Your Health and Well-being?. London (UK): The Stationery Office, 2006.
Waltenburg 2021
    1. Waltenburg MA, Rose CE, Victoroff T, Butterfield M, Dillaha JA, Heinzerling A, et al. Coronavirus disease among workers in food processing, food manufacturing, and agriculture workplaces. Emerging Infectious Diseases 2021;27(1):243-9. [DOI: 10.3201/eid2701.203821.] - DOI - PMC - PubMed
Wang 2023
    1. Wang B, Andraweera P, Elliott S, Mohammed H, Lassi Z, Twigger A, et al. Asymptomatic SARS-CoV-2 infection by age: a global systematic review and meta-analysis. Pediatric Infectious Disease Journal 2023;42(3):232-9. [DOI: 10.1097/INF.0000000000003791] - DOI - PMC - PubMed
WHO 2020
    1. World Health Organization. Coronavirus. www.who.int/health-topics/coronavirus#tab=tab_1 (accessed 29 March 2021).
WHO 2023
    1. World Health Organization. From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic. www.who.int/publications/i/item/WHO-WHE-SPP-2023.1.
Yu 2020
    1. Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. Journal of Infectious Diseases 2020;221(11):1757-61. - PMC - PubMed

References to other published versions of this review

Pizarro 2021
    1. Pizarro AB, Persad E, Durao S, Nussbaumer-Streit B, Garritty C, Engela-Volker JS, et al. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings. Cochrane Database of Systematic Reviews 2021, Issue 9. Art. No: CD015112. [DOI: 10.1002/14651858.CD015112] - DOI - PMC - PubMed
Pizarro 2022
    1. Pizarro AB, Persad E, Durao S, Nussbaumer-Streit B, Engela-Volker JS, McElvenny D, et al. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings. Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No: CD015112. [DOI: 10.1002/14651858.CD015112.pub2] [PMID: ] - DOI - PMC - PubMed

Publication types

Associated data